QS Investors, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 140 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$719,000
+29.1%
155,683
-2.2%
0.01%
+14.3%
Q4 2018$557,000
-65.3%
159,1330.0%0.01%
-53.3%
Q3 2018$1,604,000
+39.2%
159,1330.0%0.02%
+36.4%
Q2 2018$1,152,000
+19.9%
159,133
+0.0%
0.01%
+10.0%
Q1 2018$961,000
-41.6%
159,107
-7.0%
0.01%
-33.3%
Q4 2017$1,646,000
+2.8%
171,071
-5.1%
0.02%
+15.4%
Q3 2017$1,601,000
-29.8%
180,3090.0%0.01%
-31.6%
Q2 2017$2,281,000
+19.2%
180,309
-1.0%
0.02%
+18.8%
Q1 2017$1,914,000
+14.2%
182,1350.0%0.02%
+14.3%
Q4 2016$1,676,000
-21.9%
182,1350.0%0.01%
-17.6%
Q3 2016$2,147,000
-8.9%
182,1350.0%0.02%
-15.0%
Q2 2016$2,357,000
-19.1%
182,1350.0%0.02%
-28.6%
Q1 2016$2,912,000
-44.2%
182,1350.0%0.03%
-44.0%
Q4 2015$5,215,000
-1.5%
182,135
-2.1%
0.05%
-9.1%
Q3 2015$5,295,000
-21.7%
186,036
-1.2%
0.06%
-33.7%
Q2 2015$6,761,000
+23.6%
188,236
+100.0%
0.08%
+33.9%
Q1 2015$5,470,000
+37.8%
94,1180.0%0.06%
+34.8%
Q4 2014$3,969,00094,1180.05%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders